'New Pre-natal Test Cheaper, More Accurate'

"); jQuery("#212 h3").html("

"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1481079_1_20190917183404.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1481079-20190917.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1481079-20190917.htm', 'DCS.dcsqry', '' ); } } }); }); });
2019-09-17 HKT 17:17
Chinese University researchers say a new pre-natal test they introduced earlier this year has proven to be more effective than conventional tests in identifying rare, life-threatening genetic disorders in foetuses.
While rare genetic disorders like Williams-Beuren, Prader Willi or Angelman only affect up to one in every ten thousand babies, these conditions can cause severe problems, ranging from intellectual disability to delayed growth and heart problems.
Chinese University scientists say their new test, Low-pass Whole-Genome Sequencing, is better than the old test at identifying such problems, and it's 40 percent cheaper to boot.
Researchers ran parallel tests on around a thousand expectant mothers. The new test identified 138 genetic abnormalities – 17 more than the old test.
Professor Richard Choy of the university's medical faculty compared the old test to something like a sub-standard fishing net.
“The deficiency of the micro-array is that the net is not even, so some of the space is larger, some of the space is smaller. So if you use that net to catch a fish, you may not be able to have a good selection of what you want”, he explained.
Studies were launched in 2016, and the new test is now available to the general public – in a first for Asia.
Researchers say the 1.7 percent increase in the diagnosis rate may not sound like much, but this means that affected families can make a more informed decision on whether to continue on with the pregnancy or not.
These kinds of invasive gene tests are usually conducted after initial screening –via ultrasound or tests for Down's syndrome.
TOPPAN Edge Becomes Japans First Qualified VLEI Issuer
The Global Legal Entity Identifier Foundation (GLEIF) has announced TOPPAN Edge, a subsidiary of TOPPAN Holdings that p... Read more
SFC And Dubais DFSA Partner On Cross-Border Regulatory Cooperation
The Dubai Financial Services Authority (DFSA), the independent regulator of the Dubai International Financial Centre (D... Read more
Toss To Launch Finance Super-App In Australia, Plans Won-Based Stablecoin
South Korea’s fintech unicorn Toss is preparing to launch its finance super-app in Australia before the end of this y... Read more
China Funds Research On Stablecoins And Cross-Border Oversight
China’s largest government-backed research funder has begun accepting applications for studies on stablecoins and the... Read more
XTransfer, CZBank Shanghai Branch Form Cross-Border Finance Partnership
XTransfer has entered into a partnership with the Shanghai branch of China Zheshang Bank (CZBank). The agreement was si... Read more
Brinc Launches VentureVerse Through Acquisition Of OG Club
Brinc, a Hong Kong-based venture acceleration and corporate innovation firm, has acquired OG Club, a decentralised auto... Read more